ANI Pharmaceuticals
ANIP
ANIP
163 hedge funds and large institutions have $422M invested in ANI Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 46 increasing their positions, 54 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
15% less repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 54
82% less call options, than puts
Call options by funds: $4.01M | Put options by funds: $22.4M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
163
Holding in Top 10
–
Calls
$4.01M
Puts
$22.4M
Top Buyers
| 1 | +$17.3M | |
| 2 | +$6.09M | |
| 3 | +$3.18M | |
| 4 |
MWNA
Marshall Wace North America
New York
|
+$3.02M |
| 5 |
Nomura Holdings
Tokyo,
Japan
|
+$2.82M |
Top Sellers
| 1 | -$14.7M | |
| 2 | -$9.24M | |
| 3 | -$4.88M | |
| 4 |
Renaissance Technologies
New York
|
-$3.67M |
| 5 |
JP Morgan Chase
New York
|
-$3.31M |